Commonwealth Equity Services, LLC Immuno Gen, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$12.46 - $29.95 $23,636 - $56,815	-1,897 Reduced 7.33%	23,980 $711,000
Q3 2023 Oct 23, 2023	SELL	$14.09 - $19.87 $21,163 - $29,844	-1,502 Reduced 5.49%	25,877 $411,000
Q2 2023 Aug 10, 2023	SELL	$3.75 - $20.05 $569,400 - $3.04 Million	-151,840 Reduced 84.72%	27,379 $517,000
Q1 2023 May 11, 2023	BUY	$3.67 - $4.92 $37,158 - $49,815	10,125 Added 5.99%	179,219 $688,000
Q4 2022 Feb 07, 2023	BUY	$4.55 - $6.31 $10,960 - $15,200	2,409 Added 1.45%	169,094 $838,000
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $4,049 - $5,848	-904 Reduced 0.54%	166,685 $796,000
Q2 2022 Jul 19, 2022	BUY	$3.15 - $5.76 $433,232 - $792,195	137,534 Added 457.61%	167,589 $754,000
Q1 2022 May 04, 2022	SELL	$4.26 - $7.48 $685 - $1,204	-161 Reduced 0.53%	30,055 $143,000
Q4 2021 Jan 31, 2022	SELL	$4.75 - $7.5 $570 - $900	-120 Reduced 0.4%	30,216 $224,000
Q3 2021 Oct 29, 2021	BUY	$5.02 - $6.59 $34,286 - $45,009	6,830 Added 29.06%	30,336 $172,000
Q2 2021 Aug 11, 2021	SELL	$5.79 - $8.6 $119,158 - $176,988	-20,580 Reduced 46.68%	23,506 $154,000
Q1 2021 May 04, 2021	BUY	$6.5 - $10.53 $122,382 - $198,258	18,828 Added 74.54%	44,086 $357,000
Q4 2020 Feb 11, 2021	SELL	$3.7 - $7.66 $1,724 - $3,569	-466 Reduced 1.81%	25,258 $162,000
Q3 2020 Nov 05, 2020	BUY	$3.45 - $4.89 $7,838 - $11,110	2,272 Added 9.69%	25,724 $92,000
Q2 2020 Aug 12, 2020	SELL	$3.32 - $5.34 $74,856 - $120,400	-22,547 Reduced 49.02%	23,452 $107,000
Q1 2020 May 11, 2020	BUY	$2.12 - $6.8 $17,814 - $57,140	8,403 Added 22.35%	45,999 $156,000
Q4 2019 Feb 05, 2020	SELL	$2.25 - $5.8 $41,598 - $107,230	-18,488 Reduced 32.96%	37,596 $191,000
Q3 2019 Oct 30, 2019	BUY	$2.22 - $3.39 $93,712 - $143,102	42,213 Added 304.33%	56,084 $135,000
Q2 2019 Jul 19, 2019	SELL	$1.8 - $3.3 $39,344 - $72,131	-21,858 Reduced 61.18%	13,871 $30,000
Q1 2019 May 13, 2019	BUY	$2.41 - $5.91 $51,234 - $125,640	21,259 Added 146.92%	35,729 $96,000
Q4 2018 Feb 11, 2019	SELL	$3.94 - $9.7 $2,533 - $6,237	-643 Reduced 4.25%	14,470 $69,000
Q3 2018 Nov 06, 2018	SELL	$8.6 - $11.26 $189 - $247	-22 Reduced 0.15%	15,113 $143,000
Q2 2018 Jul 31, 2018	BUY	$9.52 - $12.15 $10,938 - $13,960	1,149 Added 8.22%	15,135 $147,000
Q1 2018 May 14, 2018	SELL	$6.7 - $12.95 $11,336 - $21,911	-1,692 Reduced 10.79%	13,986 $147,000
Q4 2017 Feb 12, 2018	BUY	$5.07 - $7.92 $79,487 - $124,169	15,678	15,678 $101,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account